Clinical Trial

Fertility Outcomes of Ovarian Tissue Cryopreservation

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
With the advancement of assisted reproductive technology, more young cancer patients can consider having children. Ovaries and testes are important reproductive organs, and drugs, diseases, chemotherapy, and radiotherapy can all damage them. Reproductive preservation technology aims to protect patients whose reproductive ability has been damaged due to gonadotoxic drug therapy. Women can preserve their reproductive ability by freezing ovarian tissue cryopreservation so that they can have children in the future. Patients who have undergone or will undergo ovarian tissue cryopreservation in Hong Kong Children's Hospital will be invited to participate in the study. Here, we aim to evaluate the outcomes after ovarian tissue cryopreservation.
Trial Details
NCT Number NCT07339995
Lead Sponsor Chinese University of Hong Kong
Conditions Neoplasms
Enrollment 100 participants
Start Date 2026-01-15
Primary Completion 2031-01-14 (estimated)
Study Completion 2032-01-14 (estimated)
Updated on ClinicalTrials.gov 2026-01-14